trial · primary record
ORKA-002
Hidradenitis Suppurativa (HS)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 200 |
| Primary completion | 2029-09 |
| Primary endpoint | Proportion of participants achieving HiSCR75 at Week 16 |
| Registry ID | NCT07783542 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:57.305Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07783542
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.